Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

microRNA-329 suppresses epithelial-to-mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3.

Liao CH, Liu Y, Wu YF, Zhu SW, Cai RY, Zhou L, Yin XM.

J Cell Physiol. 2019 Mar 18. doi: 10.1002/jcp.28404. [Epub ahead of print]

PMID:
30887508
2.

MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.

Cao Q, Liu F, Ji K, Liu N, He Y, Zhang W, Wang L.

J Exp Clin Cancer Res. 2017 Feb 13;36(1):29. doi: 10.1186/s13046-017-0499-z.

3.

MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.

Lu C, Shan Z, Hong J, Yang L.

Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.

PMID:
28534966
4.

EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.

Ma J, Zhang J, Weng YC, Wang JC.

Mol Cells. 2018 Sep 30;41(9):868-880. doi: 10.14348/molcells.2018.0109. Epub 2018 Sep 18.

6.

Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.

Li LQ, Pan D, Chen Q, Zhang SW, Xie DY, Zheng XL, Chen H.

Cell Physiol Biochem. 2018;47(4):1533-1545. doi: 10.1159/000490871. Epub 2018 Jun 21.

7.

microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.

Wang SH, Li X, Zhou LS, Cao ZW, Shi C, Zhou CZ, Wen YG, Shen Y, Li JK.

Tumour Biol. 2013 Dec;34(6):3705-12. doi: 10.1007/s13277-013-0954-1. Epub 2013 Jul 20.

PMID:
23873106
8.

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.

Yu J, Xie F, Bao X, Chen W, Xu Q.

Mol Cancer. 2014 May 24;13:121. doi: 10.1186/1476-4598-13-121.

9.

Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma.

Zhang D, Li H, Jiang X, Cao L, Wen Z, Yang X, Xue P.

J Hematol Oncol. 2017 Oct 30;10(1):170. doi: 10.1186/s13045-017-0528-6.

10.

microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis.

Yang MH, Yu J, Jiang DM, Li WL, Wang S, Ding YQ.

J Transl Med. 2014 May 1;12:109. doi: 10.1186/1479-5876-12-109.

11.

microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2.

Cao J, Liu J, Long J, Fu J, Huang L, Li J, Liu C, Zhang X, Yan Y.

Biomed Pharmacother. 2017 May;89:642-650. doi: 10.1016/j.biopha.2017.02.030. Epub 2017 Mar 3.

PMID:
28262617
12.

MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.

Liu B, Hu Y, Qin L, Peng XB, Huang YX.

Dig Liver Dis. 2019 Mar;51(3):397-411. doi: 10.1016/j.dld.2018.08.021. Epub 2018 Aug 30.

PMID:
30314946
13.

miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.

Qiu YH, Wei YP, Shen NJ, Wang ZC, Kan T, Yu WL, Yi B, Zhang YJ.

Cell Physiol Biochem. 2013;32(5):1331-41. doi: 10.1159/000354531. Epub 2013 Nov 22.

14.
15.

Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer.

Huang L, Wang X, Wen C, Yang X, Song M, Chen J, Wang C, Zhang B, Wang L, Iwamoto A, Wang J, Liu H.

Sci Rep. 2015 Aug 25;5:13350. doi: 10.1038/srep13350.

16.

MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.

Hong X, Yu JJ.

Am J Physiol Cell Physiol. 2019 Apr 1;316(4):C463-C480. doi: 10.1152/ajpcell.00142.2018. Epub 2018 Dec 19.

PMID:
30566393
17.

MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling.

Qu J, Li M, An J, Zhao B, Zhong W, Gu Q, Cao L, Yang H, Hu C.

Int J Oncol. 2015 Dec;47(6):2141-52. doi: 10.3892/ijo.2015.3187. Epub 2015 Sep 28.

PMID:
26459797
18.

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.

Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY.

Breast Cancer Res Treat. 2012 Aug;134(3):1081-93. doi: 10.1007/s10549-012-2034-4. Epub 2012 Apr 4.

PMID:
22476851
19.

microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.

Wang D, Lu G, Shao Y, Xu D.

Biosci Rep. 2017 Mar 15;37(2). pii: BSR20160521. doi: 10.1042/BSR20160521. Print 2017 Apr 30.

20.

Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.

Li Q, Ran P, Zhang X, Guo X, Yuan Y, Dong T, Zhu B, Zheng S, Xiao C.

Cell Physiol Biochem. 2018;50(3):987-1004. doi: 10.1159/000494482. Epub 2018 Oct 24.

Supplemental Content

Support Center